Nutrigenomics Market Set to Witness Significant Growth by 2028 Due to Impact of COVID-19 – The Bollywood Ticket


The Global Nutrigenomics market The size is expected to reach USD 1,393.9 million in 2028 and register a CAGR of 16.2% over the forecast period, according to the latest report from Reports and Data. Factors such as the growing preference for personalized medicines and diets, the increasing application of nutrigenomics in dermatology, increasing investment in pharmaceutical and biotechnology research and development activities, and the higher prevalence of obesity are expected to drive the market revenue growth over the forecast period.

Nutrigenomics, also known as nutritional genomics, is a part of medical science that helps analyze the relationship between the human genome, nutrition, and health. Additionally, it helps to understand the effects of specific foods or constituents on human gene expression, as well as how genetic variations impact the nutritional environment.

Nutrigenomics is widely applied to diagnose and treat a variety of chronic diseases such as cancer, obesity, cardiovascular disease, diabetes and others. The obesity segment accounted for the largest share of revenue in 2020, driven by the growing prevalence of obesity among youth and adults due to unhealthy eating habits, stress and genetics. Nutrigenomics technologies help people build personalized diets based on their nutritional needs and overall health. Increasing investment in research and development activities by companies to introduce innovative products, as well as to provide information on human genome and nutritional science is expected to support the growth of the market in the near future.

Download the sample copy of the report:

In September 2021, for example, SAGENOME, which is a startup incubated at the Kerala Startup Mission Integrated Startup Complex (KSUM) in Kochi, India, deployed a home saliva collection kit, as well as a variety of tests based on several genomes at national level. Saliva collected from people using this new collection kit enables the analysis of multiple variations of the human genome, which further enables healthcare professionals to provide personalized health care and nutrition based on the genomic information of a person. This is expected to drive a high demand for nutrigenomics over the forecast period.

Some key highlights of the report:

  • In May 2021, GB HealthWatch launched the GBinsight Nutritional Genomics genetic testing and analysis panel. According to GB, this testing solution is designed to combat a wide range of diseases such as obesity, coronary heart disease and type 2 diabetes.
  • By product type, the reagents and kits segment accounted for a significantly stable revenue share in 2020. This is attributed to the increasing prevalence of chronic diseases such as cancer, obesity, diabetes, cardiovascular diseases and others . Additionally, increasing healthcare expenditures and growing number of advanced clinical laboratories in emerging economies are supporting the growth of this segment.
  • North America is expected to account for the largest share of revenue during the forecast period. Rising investment in clinical research activities by companies, presence of numerous key players, and high demand for specialized diets and diets are some of the major factors driving the market revenue growth in this region.
  • Some major companies profiled in the market report are BASF SE, Danone, Navigenics, GeneSmart, XCODE Life Sciences Pvt. Ltd., Unilever, Centogene, Genova Diagnostics, Inc., Nutrigenomix, Inc. and Metagenics, Inc., among others.

Customization request:

For the purposes of this report, Reports and Data has segmented the global nutrigenomics market on the basis of product type, application, distribution channel and region:

Product Type Outlook (Revenue, USD Million; 2018-2028)

Application Outlook (Revenue, USD Million; 2018-2028)

  • Cardiovascular illnesses
  • Obesity
  • Research against cancer

Distribution Channel Outlook (Revenue, USD Million; 2018-2028)

  • Online platforms
  • Hospitals and Clinics
  • Others

Regional Outlook (Revenue, USD Million; 2018-2028)

  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • The rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Israel
    • Rest of MEA

Inquiry before buying:

Key Questions Answered by the Report

  • What was the market size of the global nutrigenomics market in 2020?
  • What is the expected compound annual growth rate (CAGR) of revenue of the global nutrigenomics market during the forecast period?
  • What factors should drive the adoption of nutrigenomics?
  • Which region is expected to account for the largest revenue share in the global Nutrigenomics market?
  • What are the major companies operating in the global market?

Contact us:

Jean W

Business Development Manager

Direct line: +1-212-710-1370

E-mail: [email protected]

Reports and data | The Web:


Read the latest press release:

Source link


Comments are closed.